Fidelity Investments’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-750
| Closed | -$1.95K | – | 5517 |
|
|
2024
Q3 | $1.95K | Buy |
+750
| New | +$1.95K | ﹤0.01% | 4810 |
|
|
2023
Q3 | – | Sell |
-1,409
| Closed | -$9.1K | – | 5265 |
|
|
2023
Q2 | $9.1K | Sell |
1,409
-41,759
| -97% | -$270K | ﹤0.01% | 4174 |
|
|
2023
Q1 | $325K | Sell |
43,168
-13,088
| -23% | -$98.7K | ﹤0.01% | 2832 |
|
|
2022
Q4 | $570K | Sell |
56,256
-53,277
| -49% | -$540K | ﹤0.01% | 2678 |
|
|
2022
Q3 | $1.08M | Buy |
109,533
+72,994
| +200% | +$722K | ﹤0.01% | 2585 |
|
|
2022
Q2 | $389K | Buy |
+36,539
| New | +$389K | ﹤0.01% | 2922 |
|
|
2022
Q1 | – | Sell |
-55,200
| Closed | -$789K | – | 4902 |
|
|
2021
Q4 | $789K | Sell |
55,200
-1,900
| -3% | -$27.2K | ﹤0.01% | 2713 |
|
|
2021
Q3 | $1.15M | Sell |
57,100
-1,000
| -2% | -$20.1K | ﹤0.01% | 2673 |
|
|
2021
Q2 | $1.28M | Sell |
58,100
-3,600
| -6% | -$79.2K | ﹤0.01% | 2620 |
|
|
2021
Q1 | $2.1M | Sell |
61,700
-196,900
| -76% | -$6.69M | ﹤0.01% | 2462 |
|
|
2020
Q4 | $10.4M | Buy |
+258,600
| New | +$10.4M | ﹤0.01% | 1960 |
|